NGC Bodily Injury Asbestos Trust Fund Claims
The NGC Bodily Injury Trust resolves remaining asbestos bodily-injury liabilities associated with old National Gypsum Company and its successor entity, Asbestos Claims Management Corporation (ACMC). The Trust was established through ACMC’s Chapter 11 reorganization after an earlier National Gypsum reorganization and settlement-trust structure proved insufficient for projected future bodily-injury claims. The Trust remains active and its official website currently states a 40% NGC Bodily Injury Trust Payment Percentage. Its Eighth Amended Claims Resolution Procedures use Allowed Liquidated Values rather than the Scheduled/Average/Maximum terminology used by many other asbestos trusts.
NGC Bodily Injury Trust Facts
| Official trust name | NGC Bodily Injury Trust |
|---|---|
| Asbestos company | Old National Gypsum Company |
| Successor debtor | Asbestos Claims Management Corporation (ACMC) |
| Original National Gypsum Chapter 11 filing | October 28, 1990 |
| 1993 Plan confirmation | March 9, 1993 |
| ACMC reorganization plan filed | August 19, 2002 |
| ACMC Plan confirmation | August 6, 2003 |
| Official website payment rate | 40% |
| Mesothelioma ER Allowed Liquidated Value | $22,500 |
| Mesothelioma IR Baseline ALV | $45,000 |
| Mesothelioma Extraordinary Claim Maximum | $180,000 |
| Current status | Active; official claim forms, procedures and payment information remain available |
National Gypsum Bankruptcy and Trust History
The Trust’s official history states that old National Gypsum Company was incorporated in Delaware in 1925 and manufactured or sold building and construction products, some of which contained asbestos. Old National Gypsum and its parent filed Chapter 11 on October 28, 1990 in the U.S. Bankruptcy Court for the Northern District of Texas.
The 1993 reorganization created a new National Gypsum operating company and renamed old National Gypsum as Asbestos Claims Management Corporation. The 1993 Plan also established the NGC Settlement Trust to resolve asbestos bodily-injury and property-damage liabilities.
After projected bodily-injury liabilities exceeded the resources available under that structure, ACMC and related parties negotiated additional funding and a new Section 524(g) qualified settlement structure. ACMC filed its reorganization plan on August 19, 2002. The Plan was confirmed August 6, 2003 and established the NGC Bodily Injury Trust to resolve the remaining asbestos bodily-injury liabilities of old National Gypsum/ACMC.
Who May Qualify for an NGC Claim?
The Eighth Amended Claims Resolution Procedures require evidence supporting a legally viable asbestos bodily-injury claim resulting from exposure to ACMC Products, defined as asbestos-containing products manufactured, sold or distributed by old National Gypsum Company.
Compensable disease categories include Mesothelioma, Lung Cancer, Other Cancer, Non-Malignant I, Non-Malignant II and Non-Malignant III. Medical and exposure criteria vary by disease and review track.
The Trust also provides procedures for exigent claims, Extraordinary Claims, secondary exposure and other claim circumstances. Living mesothelioma claimants are automatically treated as exigent claims under the CRP.
Allowed Liquidated Values
The Eighth Amended CRP publishes the following Allowed Liquidated Value framework:
| Disease | ER ALV | IR Baseline ALV | Extraordinary Claim Maximum |
|---|---|---|---|
| Mesothelioma | $22,500 | $45,000 | $180,000 |
| Lung Cancer | $3,750 | $7,500 | $30,000 |
| Other Cancer | $1,600 | $3,200 | $12,800 |
| Non-Malignant I | $1,000 | $2,000 | $8,000 |
| Non-Malignant II | $500 | $1,000 | $4,000 |
| Non-Malignant III | $250 | Not applicable | Not applicable |
The CRP explains that ER values are 50% of the IR Baseline ALVs because ER claims are intended to be processed more quickly and with less demanding review. Non-Malignant III claims may only be allowed as Expedited Review claims.
Need help now? Call 800.291.0963
Live chat available 24/7, 365 days a year.
Submit Your Case
Official NGC Payment Percentage
The NGC Bodily Injury Trust’s official FAQ currently states: “The NGCBIT Payment Percentage is currently 40%.” The same official page explains that, after an Allowed Claim’s properly executed Release & Indemnity is received, the claim is paid at the Allowed Liquidated Value multiplied by the then-current Payment Percentage.
The Eighth Amended CRP requires the Trustees to reconsider the Payment Percentage at least every two years based on projected present and future claims, Trust assets and earnings, administrative costs and other material factors. It also permits supplemental payments when authorized after an increase in the percentage.
Mathematical illustration only — not a guaranteed payment. Using the official FAQ’s displayed 40% rate, a $22,500 Mesothelioma ER ALV × 40% = $9,000. A $45,000 Mesothelioma IR Baseline ALV × 40% = $18,000 before any claim-specific IR adjustment.
Some non-primary websites report a different NGC percentage. Under this page’s primary-source standard, those secondary figures are not substituted for the rate currently displayed by the Trust itself. Claimants should verify the then-current percentage with the Trust when a claim is liquidated because the CRP permits the percentage to change.
Expedited and Individual Review
Expedited Review (ER) uses the ER Allowed Liquidated Values published in Exhibit 1. The ER payment is the applicable ER ALV multiplied by the then-current NGC Payment Percentage after the claim is allowed and the required release is received.
Individual Review (IR) begins with the published Baseline ALV but evaluates claim-specific factors associated with historical ACMC settlement values. The CRP identifies factors such as medical and exposure criteria, occupation, claimant age and jurisdiction. An IR value may therefore be higher or lower than the Baseline ALV.
Extraordinary Claim treatment is available to a limited number of qualifying IR claimants and can permit valuation up to the published Extraordinary Claim Maximum, subject to the CRP.
Medical and Exposure Requirements
The CRP requires a medical report from a Qualified Physician diagnosing an asbestos-related injury and generally requires documentation that at least 10 years elapsed between first asbestos exposure and diagnosis.
Mesothelioma may be established through a qualified diagnosis referencing pathological findings from a board-certified pathologist or, where adequate tissue is unavailable, a reasonably equivalent clinical diagnosis by a Qualified Physician.
Exposure evidence should establish a legally viable exposure to an ACMC/National Gypsum asbestos-containing product. The CRP describes evidence concerning occupation, job duties, industry, employer or job site, time period and the frequency, duration and nature of exposure. The Trust may request supporting documentation.
The official occupation and industry materials identify numerous occupations used in claim evaluation and separately identify presumptive occupations for specified exposure circumstances.
Claim Administration and Payment Procedures
The Trust’s official site provides claim forms, Claims Resolution Procedures, law-firm registration materials, electronic filer agreements, exposure-policy materials, occupation and industry lists and other filing resources.
The official FAQ states that payments are scheduled on a monthly basis, although the schedule may be accelerated when payment volume warrants. Claims must satisfy the CRP’s medical, exposure and legal requirements before payment.
A current official audited financial report establishing 2025 or 2026 total assets, cumulative claims paid and lifetime dollars paid was not located in the Trust’s public primary-source materials reviewed for this page. Those statistics are therefore omitted rather than copied from secondary websites.
Confirmed Primary Sources for Trust Facts
No law-firm or lead-generation website was used as factual authority for this page. Primary Trust materials reviewed include:
Related Asbestos Trust Fund Resources
Asbestos Trust Fund Information
Filing and Eligibility
Payments and Claim Rules
Frequently Asked Questions About the NGC Bodily Injury Trust
What company is associated with the NGC Bodily Injury Trust?
The Trust resolves remaining asbestos bodily-injury liabilities of old National Gypsum Company and Asbestos Claims Management Corporation.
Is the NGC Bodily Injury Trust active?
Yes. Its official website continues to provide claim forms, current procedures, payment information and filing resources.
What Payment Percentage does the official NGC website currently display?
The official NGC FAQ currently states a 40% Payment Percentage. Because the CRP permits the percentage to change, claimants should verify the then-current rate when a claim is liquidated.
What is the NGC mesothelioma Expedited Review value?
The Eighth Amended CRP lists a $22,500 ER Allowed Liquidated Value for mesothelioma.
What is the mesothelioma Individual Review Baseline ALV?
The published IR Baseline ALV for mesothelioma is $45,000, with a $180,000 Extraordinary Claim Maximum.
Does NGC require a latency period?
Yes. The CRP generally requires at least 10 years between first asbestos exposure and diagnosis.
Are living mesothelioma claims given priority?
Yes. The CRP states that living claimants filing mesothelioma claims are automatically treated as exigent claims.
How often does the NGC Trust schedule payments?
The official FAQ states that payments are scheduled monthly, with adjustments possible when payment volume warrants.
Get Help Reviewing an NGC Bodily Injury Trust Claim
Call 800.291.0963
Live chat is available 24/7, 365 days a year.
Prior exposure to a National Gypsum asbestos-containing product does not automatically establish eligibility for an NGC Bodily Injury Trust claim or other asbestos compensation. Eligibility depends on medical evidence, product and exposure evidence, current Trust procedures, applicable law and individual circumstances. Compensation is not guaranteed.
⚕️ Legal & Medical Information Disclaimer
This page provides general educational information and is not medical or legal advice. The information does not establish asbestos exposure, diagnosis, causation, liability, claim eligibility or compensation. Medical concerns should be discussed with a qualified healthcare professional, and legal questions should be reviewed with a qualified attorney.